This is a fundamentally different type of appetite suppression than what GLP-1 agonists provide
One important caveat
It suggests either multiple pathways activated at different dose ranges or extreme potency with receptor saturation at low doses
Last reviewed: June 4, 2026 Last updated: June 4, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Sources NIH Office of Dietary Supplements, Vitamin B12 Fact Sheet NIH Office of Dietary Supplements, Choline Fact Sheet MedlinePlus, Cyanocobalamin Injection Mayo Clinic, Vitamin B12 Injections and Weight Loss NCBI Bookshelf, Essential Amino Acids PubMed, Inositol Phosphate Signaling Network The American Journal of Clinical Nutrition, Lipotropic Agents and Lipid Transport